Endonovo Therapeutics, Inc. (ENDV)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Endonovo Therapeutics Net Income (Quarterly) : -0.5884M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5884M |
| March 31, 2026 | -0.5865M |
| December 31, 2025 | -0.541M |
| September 30, 2025 | -0.5443M |
| June 30, 2025 | -0.5579M |
| March 31, 2025 | -0.533M |
| December 31, 2024 | -0.6695M |
| September 30, 2024 | -0.6971M |
| June 30, 2024 | -0.7213M |
| March 31, 2024 | -0.7094M |
| December 31, 2023 | -1.603M |
| September 30, 2023 | -0.7662M |
| June 30, 2023 | 2.064M |
| March 31, 2023 | 7.230M |
| December 31, 2022 | -12.93M |
| September 30, 2022 | -0.6034M |
| June 30, 2022 | -2.526M |
| March 31, 2022 | -2.413M |
| December 31, 2021 | 2.396M |
| September 30, 2021 | -1.524M |
| June 30, 2021 | -1.297M |
| March 31, 2021 | -2.681M |
| December 31, 2020 | -2.030M |
| September 30, 2020 | -1.069M |
| June 30, 2020 | -1.635M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.338M |
| December 31, 2019 | -5.664M |
| September 30, 2019 | -1.406M |
| June 30, 2019 | -7.838M |
| March 31, 2019 | -2.406M |
| December 31, 2018 | 1.382M |
| September 30, 2018 | -5.948M |
| June 30, 2018 | -1.251M |
| March 31, 2018 | -0.6189M |
| December 31, 2017 | 1.769M |
| September 30, 2017 | -6.672M |
| June 30, 2017 | 1.858M |
| March 31, 2017 | -7.765M |
| December 31, 2016 | -0.7398M |
| September 30, 2016 | -2.219M |
| June 30, 2016 | -1.454M |
| March 31, 2016 | -0.9035M |
| December 31, 2015 | -4.527M |
| September 30, 2015 | -1.281M |
| June 30, 2015 | -0.5577M |
| March 31, 2015 | -0.4802M |
| December 31, 2014 | -0.2229M |
| September 30, 2014 | 0.0946M |
| June 30, 2014 | -0.2027M |
| March 31, 2014 | -0.6285M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 3.309M |
| Accuray, Inc. | -1.941M |
| Micron Solutions, Inc. | -- |
| Perspective Therapeutics, Inc. | -26.98M |
| Orthofix Medical, Inc. | -15.80M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.5884M |
| EPS Diluted (Quarterly) | -0.0003 |
| Enterprise Value | 7.104M |
| Earnings Yield | -2.40K% |
| Normalized Earnings Yield | -2400.00 |